141 related articles for article (PubMed ID: 26131278)
1. Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors.
Liu N; Huang J; Sun S; Zhou Z; Zhang J; Gao F; Sun Q
Int J Clin Exp Med; 2015; 8(4):6495-501. PubMed ID: 26131278
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior.
Miao R; Liu N; Wang Y; Li L; Yu X; Jiang Y; Li J
Hepatogastroenterology; 2008; 55(88):2012-5. PubMed ID: 19260469
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
4. [Association of JMJD3, MMP-2 and VEGF expressions with clinicopathological features of invasive ductal breast carcinoma].
Xu X; Wang J; Yan C; Men Y; Jiang H; Fang H; Xu X; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1593-1600. PubMed ID: 33243732
[TBL] [Abstract][Full Text] [Related]
5. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
Lu CL; Ji Y; Ge D; Guo J; Ding JY
Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between expressions of matrix metalloproteinase-2 & 9 and vasculogenic mimicry in gastrointestinal stromal tumors].
Qie S; Sun BC; Zhao XL; Zhang SW; Sun T; Gao SY; Wang XH
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1106-9. PubMed ID: 19595140
[TBL] [Abstract][Full Text] [Related]
8. Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma.
Wen YL; Li L
Genet Mol Res; 2015 Dec; 14(4):19342-8. PubMed ID: 26782587
[TBL] [Abstract][Full Text] [Related]
9. Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Thammineni KL; Thakur GK; Kaur N; Banerjee BD
Mol Cell Biochem; 2019 Jul; 457(1-2):93-103. PubMed ID: 30993496
[TBL] [Abstract][Full Text] [Related]
10. [Expression of matrix metalloproteinase-2,matrix metalloproteinase-9 and vascular endothdial growth factor in retinoblastoma and its clinical significance].
Zhou L; Xu J; Kang J
Yan Ke Xue Bao; 2010 Aug; 25(1):62-4. PubMed ID: 21166045
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.
Sun WH; Sun YL; Fang RN; Shao Y; Xu HC; Xue QP; Ding GX; Cheng YL
Jpn J Clin Oncol; 2005 Dec; 35(12):707-13. PubMed ID: 16314343
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Zhang Y; Wu JZ; Zhang JY; Xue J; Ma R; Cao HX; Feng JF
Oncol Lett; 2014 Feb; 7(2):499-506. PubMed ID: 24396477
[TBL] [Abstract][Full Text] [Related]
13. Influence of VEGF, COX-2, and MMP-9 expression on the molybdenum-targeted X-ray in breast cancer.
Zhang Y; Dang S; Wan Y; Yang F; Li T
Eur J Gynaecol Oncol; 2017; 38(1):45-48. PubMed ID: 29767863
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
Donmez G; Sullu Y; Baris S; Yildiz L; Aydin O; Karagoz F; Kandemir B
Pathol Res Pract; 2009; 205(12):854-7. PubMed ID: 19762163
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical implication of Matrix Metalloproteinase-1 and Vascular Endothelial Growth Factor in retinoblastoma].
Yuan S; Song H
Yan Ke Xue Bao; 2010 Aug; 25(1):48-51. PubMed ID: 21166042
[TBL] [Abstract][Full Text] [Related]
18. Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.
Lou G; Gao Y; Ning XM; Zhang QF
World J Gastroenterol; 2005 Aug; 11(32):5032-6. PubMed ID: 16124061
[TBL] [Abstract][Full Text] [Related]
19. The expression of epidermal growth factor receptor, vascular endothelial growth factor, matrix metalloproteinase-2, and cyclooxygenase-2 in relation to human papilloma viral load and persistence of human papillomavirus after conization with negative margins.
Song SH; Lee JK; Hur JY; Kim I; Saw HS; Park YK
Int J Gynecol Cancer; 2006; 16(6):2009-17. PubMed ID: 17177839
[TBL] [Abstract][Full Text] [Related]
20. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
